Your browser doesn't support javascript.
loading
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.
Bustoros, Mark; Anand, Shankara; Sklavenitis-Pistofidis, Romanos; Redd, Robert; Boyle, Eileen M; Zhitomirsky, Benny; Dunford, Andrew J; Tai, Yu-Tzu; Chavda, Selina J; Boehner, Cody; Neuse, Carl Jannes; Rahmat, Mahshid; Dutta, Ankit; Casneuf, Tineke; Verona, Raluca; Kastritis, Efstathis; Trippa, Lorenzo; Stewart, Chip; Walker, Brian A; Davies, Faith E; Dimopoulos, Meletios-Athanasios; Bergsagel, P Leif; Yong, Kwee; Morgan, Gareth J; Aguet, François; Getz, Gad; Ghobrial, Irene M.
Afiliación
  • Bustoros M; Medical Oncology, Dana-Farber Cancer Center, Boston, MA, USA.
  • Anand S; Division of Hematology & Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Sklavenitis-Pistofidis R; Broad Institute of MIT & Harvard, Cambridge, MA, USA.
  • Redd R; Boston University School of Medicine, Boston, MA, USA.
  • Boyle EM; Medical Oncology, Dana-Farber Cancer Center, Boston, MA, USA.
  • Zhitomirsky B; Broad Institute of MIT & Harvard, Cambridge, MA, USA.
  • Dunford AJ; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Tai YT; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
  • Chavda SJ; Broad Institute of MIT & Harvard, Cambridge, MA, USA.
  • Boehner C; Broad Institute of MIT & Harvard, Cambridge, MA, USA.
  • Neuse CJ; Medical Oncology, Dana-Farber Cancer Center, Boston, MA, USA.
  • Rahmat M; Division of Hematology, University College London, London, UK.
  • Dutta A; Medical Oncology, Dana-Farber Cancer Center, Boston, MA, USA.
  • Casneuf T; Medical Oncology, Dana-Farber Cancer Center, Boston, MA, USA.
  • Verona R; University of Münster Medical School, Münster, Germany.
  • Kastritis E; Medical Oncology, Dana-Farber Cancer Center, Boston, MA, USA.
  • Trippa L; Medical Oncology, Dana-Farber Cancer Center, Boston, MA, USA.
  • Stewart C; Janssen Research and Development, Beerse, Belgium.
  • Walker BA; Janssen Research and Development, Spring House, PA, USA.
  • Davies FE; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Dimopoulos MA; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bergsagel PL; Broad Institute of MIT & Harvard, Cambridge, MA, USA.
  • Yong K; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN, USA.
  • Morgan GJ; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
  • Aguet F; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Getz G; Division of Hematology, Mayo Clinic, Scottsdale, AZ, USA.
  • Ghobrial IM; Division of Hematology, University College London, London, UK.
Nat Commun ; 13(1): 3449, 2022 06 15.
Article en En | MEDLINE | ID: mdl-35705541
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Quiescente / Mieloma Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Quiescente / Mieloma Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos